Septerna, Inc. SEPN Gain On Sale Of Non Financial Asset
Gain On Sale Of Non Financial Asset at other companies
Other financials
Where this comes from
Reported directly by Septerna, Inc. in its filing.
Tagged under the XBRL concept sepn:GainOnSaleOfNonFinancialAsset.
The official record: Septerna, Inc.’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →
Ask your AI about Septerna, Inc.'s gain on sale of non financial asset.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Septerna, Inc.'s gain on sale of non financial asset?
- Septerna, Inc. (SEPN) reported gain on sale of non financial asset of $3.13M in Q4 2025.
- What is the long-term trend for Septerna, Inc.'s gain on sale of non financial asset?
- Over 2 years (2023 to 2025), Septerna, Inc.'s gain on sale of non financial asset has grown at a -48.8% compound annual growth rate (CAGR), from $47.63M to $12.5M.
- What does gain on sale of non financial asset mean?
- This represents the non-operating profit recognized from the disposal of long-term assets that are not classified as financial instruments. It reflects gains generated outside of core drug discovery operations, often from the divestiture of equipment or property. Investors monitor this to distinguish between recurring operational performance and one-time gains from asset liquidation.